Spinal cord disease following CAR T-cell therapy with axicabtagene ciloleucel in a patient with high-grade B-cell lymphoma.
Saved in:
| Title: | Spinal cord disease following CAR T-cell therapy with axicabtagene ciloleucel in a patient with high-grade B-cell lymphoma. |
|---|---|
| Authors: | Walter, Clara1,2 (AUTHOR), Burger, Michael C.3,4 (AUTHOR), Siebenbrodt, Kai5 (AUTHOR), Mooshage, Christoph M.2,6 (AUTHOR), You, Se-Jong7 (AUTHOR), Hattingen, Elke7 (AUTHOR), Scholten, Felicitas8 (AUTHOR), Weidner, Norbert1,2 (AUTHOR), Wagner, Björn1,2 (AUTHOR), Lang, Fabian9 (AUTHOR), Ajib, Salem9 (AUTHOR), Oellerich, Thomas4,9 (AUTHOR), Bug, Gesine4,9 (AUTHOR), Hug, Andreas1,2 (AUTHOR), Vischedyk, Jonas B.4,9 (AUTHOR) vischedyk@med.uni-frankfurt.de |
| Source: | Leukemia & Lymphoma. Jul2026, Vol. 67 Issue 8, p1806-1810. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 10428194 |
|---|---|
| DOI: | 10.1080/10428194.2026.2647957 |
